Neuronetics Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +13.6% | -14.3% | -5.6% | +12.6% | +21.4% | +42.2% | +19.2% | -2.1% | +12.0% | -17.5% | +20.6% | – | |
| – | -25.8% | -4.7% | -1.3% | +6.0% | +67.8% | +113.6% | +25.3% | -0.8% | -0.6% | -8.8% | +11.2% | – | |
| – | +34.1% | -17.0% | -6.9% | +15.0% | +6.4% | +5.7% | +12.8% | -3.7% | +26.9% | -25.6% | +31.4% | – | |
| – | +2.4% | +6.4% | -4.9% | +8.1% | +138.9% | -72.0% | +11.3% | -16.4% | +10.8% | -18.1% | -2.1% | – | |
| – | -1.0% | -5.1% | +3.2% | +20.9% | +45.0% | +21.8% | -7.5% | -8.8% | +20.4% | -2.2% | -12.6% | – | |
| – | -2.1% | -1.2% | +3.7% | +5.0% | +21.3% | +1.5% | -3.5% | -5.4% | +9.5% | -6.0% | -9.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +55.7% | -0.9% | +8.3% | -12.8% | -7.2% | +20.1% | +2.4% | +5.6% | +1.0% | +7.9% | -6.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -489.4% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.